End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 EUR | +35.71% | +35.71% | -60.69% |
May. 15 | Acticor: 'new perspectives' in stroke treatment | CF |
Apr. 30 | Acticor Biotech SAS Announces Postponement in Publication of 2023 Annual Results | CI |
Evolution of the average Target Price on Acticor Biotech SAS
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALACT Stock
- Consensus Acticor Biotech SAS